Skip to main content
SpringerLink
Log in

Management of Lymphatic Malformations

  • Chapter
  • First Online:
Congenital Vascular Malformations

Abstract

Lymphatic malformations (LMs) are congenital anomalies of the lymphatic system occurring in 1 in 2000–4000 births. These anomalies are present at birth but may not be apparent until later in life. Other congenital vascular malformations include venous malformations (VMs), capillary malformations (CMs) and arteriovenous malformations (AVMs). VMs are the most common vascular malformations followed by LMs and CMs. Fortunately, AVMs are the least common but the most aggressive and the most difficult to treat.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds Jr JL, Hoffer FA, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg. 2010;142(6):795–803. e1

    Article  PubMed  Google Scholar 

  2. Parsi K, Myers KA. Tumours and fistulae. In: Myers KA, Clough AM, editors. Practical vascular ultrasound: an illustrated guide. Boca Raton: CRC Press; 2014. p. 215–28.

    Google Scholar 

  3. Sierre S, Teplisky D, Lipsich J. Vascular malformations: an update on imaging and management. Arch Argent Pediatr. 2016;114(2):167–76.

    PubMed  Google Scholar 

  4. Koo HJ, Lee JH, Kim GY, Choi YJ, Baek JH, Choi SH, Nam SY, Kim SY, Suh DC. Ethanol and/or radiofrequency ablation to treat venolymphatic malformations that manifest as a bulging mass in the head and neck. Clin Radiol. 2016;71(10):1070.e1–7.

    Google Scholar 

  5. Ha J, Yu YC, Lannigan F. A review of the management of lymphangiomas. Curr Pediatric Rev. 2014;10(3):238–48.

    Article  Google Scholar 

  6. Adams DM, Trenor 3rd CC, Hammill AM, Vinks AA, Patel MN, Chaudry G, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137(2):e20153257.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018–24.

    Article  PubMed  Google Scholar 

  8. Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH, et al. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol. 2014;70(6):1050–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Koshy JC, Eisemann BS, Agrawal N, Pimpalwar S, Edmonds JL. Sildenafil for microcystic lymphatic malformations of the head and neck: a prospective study. Int J Pediatr Otorhinolaryngol. 2015;79(7):980–2.

    Article  PubMed  Google Scholar 

  10. Rankin H, Zwicker K, Trenor 3rd CC. Caution is recommended prior to sildenafil use in vascular anomalies. Pediatr Blood Cancer. 2015;62(11):2015–7.

    Article  PubMed  Google Scholar 

  11. Ozeki M, Kanda K, Kawamoto N, Ohnishi H, Fujino A, Hirayama M, et al. Propranolol as an alternative treatment option for pediatric lymphatic malformation. Tohoku J Exp Med. 2013;229(1):61–6.

    Article  CAS  PubMed  Google Scholar 

  12. Gilony D, Schwartz M, Shpitzer T, Feinmesser R, Kornreich L, Raveh E. Treatment of lymphatic malformations: a more conservative approach. J Pediatr Surg. 2012;47(10):1837–42.

    Article  PubMed  Google Scholar 

  13. Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA otolaryngol Head Neck Surg. 2014;140(1):41–5.

    Article  PubMed  Google Scholar 

  14. Goswamy J, Penney SE, Bruce IA, Rothera MP. Radiofrequency ablation in the treatment of paediatric microcystic lymphatic malformations. J Laryngol Otol. 2013;127(3):279–84.

    Article  CAS  PubMed  Google Scholar 

  15. Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol. 2011;47(12):1105–9.

    Article  PubMed  Google Scholar 

  16. Manning SC, Perkins J. Lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg. 2013;21(6):571–5.

    Article  PubMed  Google Scholar 

  17. Francis CS, Rommer EA, Kane JT, Iwata K, Panossian A. Limited-incision surgical debulking of lymphatic malformations using ultrasound-assisted liposuction. Plast Reconstr Surg. 2012;130(6):920e-2e.

    Article  Google Scholar 

  18. Tavakkolizadeh A, Wolfe KQ, Kangesu L. Cutaneous lymphatic malformation with secondary fat hypertrophy. Br J Plast Surg. 2001;54(4):367–9.

    Article  CAS  PubMed  Google Scholar 

  19. Mitsukawa N, Satoh K. New treatment for cystic lymphangiomas of the face and neck: cyst wall rupture and cyst aspiration combined with sclerotherapy. J Craniofac Surg. 2012;23(4):1117–9.

    Article  PubMed  Google Scholar 

  20. Harmoush S, Chinnadurai P, El Salek K, Metwalli Z, Herce H, Bhatt A, et al. Multimodality image-guided sclerotherapy of low-flow orbital vascular malformations: report of single-center experience. J Vasc Interv Radiol. 2016;27:987–95.

    Article  PubMed  Google Scholar 

  21. Schook CC, Mulliken JB, Fishman SJ, Grant FD, Zurakowski D, Greene AK. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011;127(6):2419–31.

    Article  CAS  PubMed  Google Scholar 

  22. Connor DE, Cooley-Andrade O, Goh WX, Ma DD, Parsi K. Detergent sclerosants are deactivated and consumed by circulating blood cells. Eur J Vasc Endovasc Surg. 2015;49(4):426–31.

    Article  CAS  PubMed  Google Scholar 

  23. Parsi K, Exner T, Connor DE, Herbert A, Ma DD, Joseph JE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg. 2008;36(2):216–23.

    Article  CAS  PubMed  Google Scholar 

  24. Furukawa H, Sasaki S, Oyama A, Hayashi T, Funayama E, Saito N, et al. Ethanol sclerotherapy with ‘injection and aspiration technique’ for giant lymphatic malformation in adult cases. J Plastic Reconstruct Aesthetic Surg. 2011;64(6):809–11.

    Article  Google Scholar 

  25. Shiels 2nd WE, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008;43(1):136–9. ; discussion 40

    Article  PubMed  Google Scholar 

  26. Farnoosh S, Don D, Koempel J, Panossian A, Anselmo D, Stanley P. Efficacy of doxycycline and sodium tetradecyl sulfate sclerotherapy in pediatric head and neck lymphatic malformations. Int J Pediatr Otorhinolaryngol. 2015;79(6):883–7.

    Article  PubMed  Google Scholar 

  27. Cheng J. Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg. 2015;50(12):2143–6.

    Article  PubMed  Google Scholar 

  28. Kiratli H, Tarlan B. Total clinical regression of an orbital macrocystic lymphatic malformation following intralesional sodium tetradecyl sulphate injection. J AAPOS. 2015;19(1):78–80.

    Article  PubMed  Google Scholar 

  29. Kok K, McCafferty I, Monaghan A, Nishikawa H. Percutaneous sclerotherapy of vascular malformations in children using sodium tetradecyl sulphate: the Birmingham experience. J Plastic Reconstruct Aesthetic Surg. 2012;65(11):1451–60.

    Article  Google Scholar 

  30. Cavezzi A, Parsi K. Complications of foam sclerotherapy. Phlebology. 2012;27(Suppl 1):46–51.

    Article  PubMed  Google Scholar 

  31. Parsi K. Interaction of detergent sclerosants with cell membranes. Phlebology. 2015;30(5):306–15.

    Article  PubMed  Google Scholar 

  32. Cabrera J, Redondo P. Sclerosing treatment of vascular malformations. An Sist Sanit Navar. 2004;27(Suppl 1):117–26.

    PubMed  Google Scholar 

  33. Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM, et al. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg. 2011;41(3):412–7.

    Article  CAS  PubMed  Google Scholar 

  34. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15(5):431–45.

    Article  PubMed  Google Scholar 

  35. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994;29(6):784–5.

    Article  CAS  PubMed  Google Scholar 

  36. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006;17(10):1639–48.

    Article  PubMed  Google Scholar 

  37. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995;30(9):1282–7.

    Article  CAS  PubMed  Google Scholar 

  38. Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, et al. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. JAMA Ophthalmol. 2014;132(8):942–8.

    Article  PubMed  Google Scholar 

  39. Spence J, Krings T, KG t B, LB d C, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol. 2010;31(5):955–60.

    Article  CAS  PubMed  Google Scholar 

  40. Lee BB, Baumgartner I, Berlien P, Bianchini G, Burrows P, Gloviczki P, et al. Diagnosis and treatment of venous malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013. Int Angiol. 2015;34(2):97–149.

    CAS  PubMed  Google Scholar 

  41. Horbach SE, Rigter IM, Smitt JH, Reekers JA, Spuls PI, van der Horst CM. Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg. 2016;137(1):244–56.

    Article  CAS  PubMed  Google Scholar 

  42. Karavelioglu A, Temucin CM, Tanyel FC, Ciftci AO, Senocak ME, Karnak I. Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation. J Pediatr Surg. 2010;45(8):1627–32.

    Article  PubMed  Google Scholar 

  43. Saitta P, Krishnamurthy K, Brown LH. Bleomycin in dermatology: a review of intralesional applications. Dermatol Surg. 2008;34(10):1299–313.

    CAS  PubMed  Google Scholar 

  44. Kirby JS, Miller CJ. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. J Am Acad Dermatol. 2010;63(4):689–702.

    Article  CAS  PubMed  Google Scholar 

  45. Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: why and how does it work? J Pediatr Surg. 1996;31(4):477–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

I am grateful to Dr. David Connor for his assistance with the preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Dermatology, St. Vincent’s Hospital, Sydney, Australia

    Kurosh Parsi

  2. University of New South Wales, Sydney, Australia

    Kurosh Parsi

Authors
  1. Kurosh Parsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kurosh Parsi .

Editor information

Editors and Affiliations

  1. Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Seoul, Korea (Republic of)

    Young-Wook Kim

  2. Professor of Surgery and Director, Center for the Lymphedema and Vascular Malformations, George Washington University, Washington, DC, USA

    Byung-Boong Lee

  3. Swedish Medical Center, Vascular malformation Center, Englewood, Colorado, USA

    Wayne F. Yakes

  4. Department of Radiology, Samsung Medical Center, Seoul, Korea (Republic of)

    Young-Soo Do

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parsi, K. (2017). Management of Lymphatic Malformations. In: Kim, YW., Lee, BB., Yakes, W., Do, YS. (eds) Congenital Vascular Malformations. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46709-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46709-1_34

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46708-4

  • Online ISBN: 978-3-662-46709-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation